Carter Percy H.

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Carter Percy H.'s trades of Blueprint Medicines Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
105.13
Quantity 4,000
Value US$420,505
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-08 2025-07-03
S Sale
58,613 -17.1%
146.26
US$2,402,633 		58,613 -17.1% 146.26 US$2,402,633
2025-06-05 2025-06-03
S Sale
12,154 +28.2%
362.38
US$2,666,501 		12,154 +28.2% 362.38 US$2,666,501
2025-06-05 2025-06-03
S Sale
49,849 +17.7%
127.67
US$147,837 		49,849 +17.7% 127.67 US$147,837
2025-03-07 2025-03-05
S Sale
3,530 -5.8%
88.80
US$313,464 		3,530 -5.8% 88.80 US$313,464
2024-06-07 2024-06-05
S Sale
4,000 -8.7%
105.13
US$420,520 		4,000 -8.7% 105.13 US$420,520
2024-06-05 2024-06-05
PrS Proposed sale
4,000
105.13
US$420,505 		4,000 105.13 US$420,505
2024-06-05 2024-06-03
S Sale
2,436 -5.0%
106.43
US$259,263 		2,436 -5.0% 106.43 US$259,263
2024-03-11 2024-03-07
S Sale
2,286 -4.5%
90.69
US$207,317 		2,286 -4.5% 90.69 US$207,317
2023-06-07 2023-06-05
S Sale
2,307 -5.7%
52.06
US$120,102 		2,307 -5.7% 52.06 US$120,102
2023-03-08 2023-03-06
S Sale
25 -0.1%
44.78
US$1,120 		25 -0.1% 44.78 US$1,120
2023-03-08 2023-03-06
S Sale
736 -1.8%
45.72
US$33,650 		736 -1.8% 45.72 US$33,650
2022-06-08 2022-06-06
S Sale
1,908 -6.2%
59.76
US$114,022 		1,908 -6.2% 59.76 US$114,022